DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Lowered by Leerink Partnrs

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by stock analysts at Leerink Partnrs from a “strong-buy” rating to a “hold” rating in a report issued on Thursday,Zacks.com reports.

Other equities analysts have also issued research reports about the stock. Needham & Company LLC dropped their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Stifel Nicolaus cut their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Robert W. Baird lowered their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday. Finally, Evercore ISI decreased their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Six equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $29.50.

DENTSPLY SIRONA Stock Up 3.5 %

Shares of DENTSPLY SIRONA stock opened at $17.86 on Thursday. The firm has a market cap of $3.62 billion, a price-to-earnings ratio of -8.63, a PEG ratio of 1.31 and a beta of 1.02. The stock’s 50-day moving average is $24.68 and its 200 day moving average is $25.90. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter last year, the firm posted $0.49 EPS. Equities research analysts anticipate that DENTSPLY SIRONA will post 1.98 EPS for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors have recently added to or reduced their stakes in the company. UMB Bank n.a. boosted its stake in shares of DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after buying an additional 753 shares during the last quarter. Capital Performance Advisors LLP purchased a new position in DENTSPLY SIRONA in the third quarter worth $27,000. LRI Investments LLC grew its stake in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares during the period. Kennebec Savings Bank purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at $35,000. Finally, Rothschild Investment LLC bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth $32,000. 95.70% of the stock is owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.